Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

69.91EUR
11:37am EST
Change (% chg)

€-1.79 (-2.50%)
Prev Close
€71.70
Open
€71.60
Day's High
€72.08
Day's Low
€69.85
Volume
4,976,208
Avg. Vol
3,270,409
52-wk High
€101.10
52-wk Low
€69.85

SASY.PA

Chart for SASY.PA

About

Sanofi SA is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging... (more)

Overall

Beta: 0.78
Market Cap(Mil.): €93,619.23
Shares Outstanding(Mil.): 1,305.71
Dividend: 2.85
Yield (%): 3.97

Financials

  SASY.PA Industry Sector
P/E (TTM): 18.04 31.76 38.72
EPS (TTM): 3.97 -- --
ROI: -- 15.12 14.47
ROE: -- 15.85 15.40
Search Stocks

EU mergers and takeovers (Feb 8)

BRUSSELS, Feb 8 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

11:30am EST

EU mergers and takeovers (Feb 5)

BRUSSELS, Feb 5 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

05 Feb 2016

EU mergers and takeovers (Feb 4)

BRUSSELS, Feb 4 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

04 Feb 2016

EU mergers and takeovers (Feb 3)

BRUSSELS, Feb 3 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

03 Feb 2016

WRAPUP 7-First U.S. Zika virus transmission reported, attributed to sex

AUSTIN, Texas, Feb 2 The first known case of Zika virus transmission in the United States was reported in Texas on Tuesday by local health officials, who said it likely was contracted through sex and not a mosquito bite, a day after the World Health Organization declared an international public health emergency.

02 Feb 2016

EU mergers and takeovers (Feb 2)

BRUSSELS, Feb 2 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

02 Feb 2016

Sanofi launches hunt for Zika vaccine as disease fears grow

PARIS/LONDON Sanofi has launched a project to develop a vaccine against the Zika virus in the most decisive commitment yet by a major vaccine producer to fight the disease linked to multiple birth defects in Brazil. | Video

02 Feb 2016

UPDATE 1-Sanofi plans 600 job cuts in France over 3 years

PARIS, Feb 2 Sanofi is considering the launch of a voluntary early retirement plan in France that could lead to around 600 job cuts over three years, the French drugmaker said on Tuesday.

02 Feb 2016

Sanofi plans 600 job cuts in France over 3 years

PARIS, Feb 2 Sanofi is considering the launch of a voluntary early retirement plan in France that could lead to around 600 job cuts over three years, the French drugmaker said on Tuesday.

02 Feb 2016

UPDATE 1-Sanofi launches hunt for Zika vaccine as disease fears grow

PARIS/LONDON, Feb 2 Sanofi has launched a project to develop a vaccine against the Zika virus in the most decisive commitment yet by a major vaccine producer to fight the disease linked to multiple birth defects in Brazil.

02 Feb 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Finlabo SIM Spa
$10.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks